JournalClinical Infectious Diseases
PublisherOxford University Press
MetadataShow full item record
AbstractThe cause of Lyme disease, Borrelia burgdorferi, was discovered in 1983. A 2-tiered testing protocol was established for serodiagnosis in 1994, involving an enzyme immunoassay (EIA) or indirect fluorescence antibody, followed (if reactive) by immunoglobulin M and immunoglobulin G Western immunoblots. These assays were prepared from whole-cell cultured B. burgdorferi, lacking key in vivo expressed antigens and expressing antigens that can bind non-Borrelia antibodies. Additional drawbacks, particular to the Western immunoblot component, include low sensitivity in early infection, technical complexity, and subjective interpretation when scored by visual examination. Nevertheless, 2-tiered testing with immunoblotting remains the benchmark for evaluation of new methods or approaches. Next-generation serologic assays, prepared with recombinant proteins or synthetic peptides, and alternative testing protocols, can now overcome or circumvent many of these past drawbacks. This article describes next-generation serodiagnostic testing for Lyme disease, focusing on methods that are currently available or near-at-hand. Copyright The Author(s) 2017.
SponsorsResearch in this area was supported in part by the Intramural and Extramural Research Programs of the National Institutes of Health (NIH), NIAID.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85044243912&doi=10.1093%2fcid%2fcix943&partnerID=40&md5=238cf3d64c6f16617a97da1d367dc257; http://hdl.handle.net/10713/9761
- Evaluation of Selected Borrelia burgdorferi lp54 Plasmid-Encoded Gene Products Expressed during Mammalian Infection as Antigens To Improve Serodiagnostic Testing for Early Lyme Disease.
- Authors: Weiner ZP, Crew RM, Brandt KS, Ullmann AJ, Schriefer ME, Molins CR, Gilmore RD
- Issue date: 2015 Nov
- Two-tiered antibody testing for Lyme disease with use of 2 enzyme immunoassays, a whole-cell sonicate enzyme immunoassay followed by a VlsE C6 peptide enzyme immunoassay.
- Authors: Branda JA, Linskey K, Kim YA, Steere AC, Ferraro MJ
- Issue date: 2011 Sep
- Editorial commentary: laboratory testing for Lyme disease: time for a change?
- Authors: Weinstein A
- Issue date: 2008 Jul 15
- Improvement of Lyme borreliosis serodiagnosis by a newly developed recombinant immunoglobulin G (IgG) and IgM line immunoblot assay and addition of VlsE and DbpA homologues.
- Authors: Goettner G, Schulte-Spechtel U, Hillermann R, Liegl G, Wilske B, Fingerle V
- Issue date: 2005 Aug
- Concordance of four commercial enzyme immunoassay and three immunoblot formats for the detection of Lyme borreliosis antibodies in human serum: the two-tier approach remains.
- Authors: Dickeson DJ, Chen SC, Sintchenko VG
- Issue date: 2016 Apr